Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
The amount that Hikma profited by infringing on | ziploc_1 | investorshub | 07/20/2024 9:15:15 PM |
Denisk, How much proof do you need - | Jasbg | investorshub | 07/20/2024 8:49:42 PM |
Hayward, Small caps and Bio stocks were | FlyFishingStocks | investorshub | 07/20/2024 6:25:43 PM |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501481/ | Number sleven | investorshub | 07/20/2024 5:27:52 PM |
yes saw that in the 13D filings. Also | Denisk | investorshub | 07/20/2024 3:11:55 PM |
Ok, then tell me what is the amount | Denisk | investorshub | 07/20/2024 2:47:12 PM |
https://www.defenseworld.net/2024/07/20/bnp-paribas-financial-markets-raises-hol | DMC8 | investorshub | 07/20/2024 2:01:09 PM |
https://www.mondaq.com/unitedstates/patent/1495098/federal-circuit-provides-insi | DMC8 | investorshub | 07/20/2024 12:18:37 PM |
https://www.medicalnewstoday.com/articles/triglyceride-medication-list | DMC8 | investorshub | 07/20/2024 12:15:28 PM |
Captain, It looks like our legal counsel may | Number sleven | investorshub | 07/20/2024 12:05:38 PM |
Good legal summary! | CaptBeer | investorshub | 07/20/2024 10:33:11 AM |
https://www.jdsupra.com/legalnews/amarin-pharma-inc-v-hikma-pharms-usa-8807022/ | Number sleven | investorshub | 07/20/2024 9:16:58 AM |
RMB, Are you surprised? | Number sleven | investorshub | 07/20/2024 8:43:42 AM |
Not sure what you mean by there isn't | rosemountbomber | investorshub | 07/20/2024 3:00:48 AM |
First right now there is no news that | Denisk | investorshub | 07/20/2024 12:29:07 AM |
Very interesting! Thanks North. | JRoon71 | investorshub | 07/19/2024 8:00:53 PM |
Another set of potentials is that 1) Cantor | north40000 | investorshub | 07/19/2024 7:31:13 PM |
I hope so........just picked up another 2k shares.....Cmon | ramfan60 | investorshub | 07/19/2024 7:00:37 PM |
I like this. And I agree that I | JRoon71 | investorshub | 07/19/2024 6:36:12 PM |
It's still my honest opinion that Sarissa is | JRoon71 | investorshub | 07/19/2024 6:34:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...